A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00674063 · COMPLETED
Trial details
- NCT number
- NCT00674063
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2004-04-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.